The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal Adenocarcinoma

被引:2
|
作者
Igarashi, Yosuke [1 ]
Shirai, Yoshihiro [1 ,2 ]
Tanji, Yoshiaki [1 ]
Hamura, Ryoga [1 ]
Yanagaki, Mitsuru [1 ]
Abe, Kyohei [1 ]
Onda, Shinji [1 ]
Furukawa, Kenei [1 ]
Matsumoto, Michinori [1 ]
Tsunematsu, Masashi [1 ]
Ikegami, Toru [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Surg, Div Hepatobiliary & Pancreas Surg, Tokyo, Japan
[2] Jikei Univ, Sch Med, 3-25-8 Nishi Shinbashi, Minato Ku, Tokyo 1058461, Japan
基金
日本学术振兴会;
关键词
pancreatic cancer; prognostic nutritional index; fibrinogen; tumor microenvironment; prognosis; PREOPERATIVE PLATELET; CANCER; LYMPHOCYTE;
D O I
10.1177/00031348231204912
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: The aim of the present study was to evaluate the prognostic value of the ratio of serum fibrinogen to prognostic nutritional index (PNI; Fbg/PNI) in patients undergoing resection for pancreatic ductal adenocarcinoma.Methods: A total of 140 patients who had undergone resection for pancreatic cancer were included. Patients were divided into two groups according to a Fbg/PNI >= 8.8 or <8.8. Survival data were analyzed using the log-rank test for univariate analysis and Cox proportional hazards for multivariate analysis.Results: Fbg/PNI was a significant prognostic indicator in univariate analysis for overall survival (OS) and disease-free survival (DFS). Fbg/PNI retained significance in multivariate analysis for OS (hazard ratio, 1.81; 95% confidence interval, 1.19-2.77; P < .01) in addition to tumor differentiation and nodal involvement. Fbg/PNI was a significant independent prognostic indicator of poor DFS on multivariate analysis (hazard ratio, 1.54; 95% confidence interval, 1.05-2.26; P = .03).Conclusion: Preoperative Fbg/PNI is a novel significant independent prognostic indicator for OS and DFS following resection of pancreatic cancer with curative intent.
引用
收藏
页码:4255 / 4261
页数:7
相关论文
共 50 条
  • [1] Prognostic role of a novel clinical-nutritional index in pancreatic ductal adenocarcinoma: The Pancreatic Adenocarcinoma Nutritional-Clinical Index (PANCIN).
    Orsi, Giulia
    Abati, Martina
    Palumbo, Diego
    Pavarini, Maddalena
    Burini, Alice
    Cardellini, Sara
    Macchini, Marina
    Mori, Martina
    Fiorino, Claudio
    Peretti, Umberto
    Valente, Maria Maddalena
    Militello, Anna Maria
    Briccolani, Maria Assunta
    Mele, Roberto
    Falconi, Massimo
    Cascinu, Stefano
    Capurso, Gabriele
    Reni, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 697 - 697
  • [2] Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
    Chung, Kwang Hyun
    Lee, Jong-Chan
    Lee, Jongchan
    Cho, In-Kuk
    Kim, Jaihwan
    Jang, Woncheol
    Yoo, Byong Chul
    Hwang, Jin-Hyeok
    PANCREATOLOGY, 2020, 20 (07) : 1465 - 1471
  • [3] The Prognostic Value of Preoperative Geriatric Nutritional Risk Index in Patients with Pancreatic Ductal Adenocarcinoma
    Hu, Si-Pin
    Chen, Lei
    Lin, Chen-Yi
    Lin, Wei-Hang
    Fang, Fu-Quan
    Tu, Meng-Yun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 385 - 395
  • [4] Prognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma
    Pergolini, I
    Crippa, S.
    Pagnanelli, M.
    Belfiori, G.
    Pucci, A.
    Partelli, S.
    Rubini, C.
    Castelli, P.
    Zamboni, G.
    Falconi, M.
    BJS OPEN, 2019, 3 (05): : 646 - 655
  • [5] Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma
    Kato, Yoshiyasu
    Yamada, Suguru
    Suenaga, Masaya
    Takami, Hideki
    Niwa, Yukiko
    Hayashi, Masamichi
    Iwata, Naoki
    Kanda, Mitsuro
    Tanaka, Chie
    Nakayama, Goro
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    PANCREAS, 2018, 47 (07) : 823 - 829
  • [6] Comparison of Prognostic Markers for Patients' Prognosis in Advanced Pancreatic Ductal Adenocarcinoma
    Suzuki, Rei
    Takagi, Tadayuki
    Hikichi, Takuto
    Watanabe, Ko
    Sugimoto, Mitsuru
    Waragai, Yuichi
    Kikuchi, Hitomi
    Asama, Hiroyuki
    Takasumi, Mika
    Ohira, Hiromasa
    GASTROENTEROLOGY, 2016, 150 (04) : S324 - S324
  • [7] Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma.
    Ninomiya, Go
    Fujii, Tsutomu
    Yamada, Suguru
    Asano, Tomonari
    Takano, Nao
    Takami, Hideki
    Iwata, Naoki
    Kanda, Mitsuro
    Niwa, Yukiko
    Hayashi, Masamichi
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Fujiwara, Michitaka
    Koike, Masahiko
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
    Cheng, Xiao-Bo
    Sato, Norihiro
    Kohi, Shiro
    Yamaguchi, Koji
    PLOS ONE, 2013, 8 (11):
  • [9] Prognostic impact of nodal statuses in patients with pancreatic ductal adenocarcinoma
    Fukuda, Yasunari
    Asaoka, Tadafumi
    Maeda, Sakae
    Hama, Naoki
    Miyamoto, Atsushi
    Mori, Masaki
    Doki, Yuichiro
    Nakamori, Shoji
    PANCREATOLOGY, 2017, 17 (02) : 279 - 284
  • [10] Fibrinogen to pre-albumin ratio is an independent prognostic index for patients with pancreatic ductal adenocarcinoma after radical resection
    Chang, Shaofei
    Zou, Yiping
    Huang, Jing
    Li, Zhifei
    Liang, Yuexiang
    Gao, Song
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)